CVRdatabase
Menu

2cureX A/S

Public limited companyCVR 29418888København ØActive

2cureX A/S is a public limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2006. Equity was negative at the end of 2025 (−DKK 194k). The company made a loss in both 2024 and 2025, most recently DKK 17.5m. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 11.6m−288.5% vs. 2024
Net profit−DKK 17.5m−374.3% vs. 2024
Equity−DKK 194k−107.1% vs. 2024
Employees7latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 3.7m to DKK 17.5m (2024 → 2025).
  • Equity turned negative: −DKK 194k (2024 → 2025).

Employees

  • 1 fewer employees than a year earlier: 7 (08/2026) against 8 (08/2025).

Registrations, last 24 months

  • 03/12/2025: Share capital changed from 500,000 DKK to 505,050 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 30m−DKK 20m−DKK 10mDKK 0DKK 10m202020212022202320242025
EquityNet profit
Financial figures for 2cureX A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit3,249−2,975−10,190−10,329−2,996−11,640−288.5%
Operating profit (EBIT)−2,728–−20,873–−8,797−18,492−110.2%
Profit before tax−4,133−11,800−19,706−28,397−8,885−18,588−109.2%
Net profit−3,230−9,210−15,353−29,742−3,692−17,508−374.3%
Total assets22,80114,07614,42710,2067,2224,958−31.3%
Equity2,656−6,55412,0456,4202,728−194−107.1%
Liabilities20,14520,6302,3813,7864,4945,152+14.6%
Cash and cash equivalents14,6563,6171,9716,8294,282679−84.2%
Average number of employees8991058+60%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2mDKK 4m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 194k at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for 2cureX A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202516/07/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202404/08/2025The companyPDFXBRL
202301/01/2023 – 31/12/202326/07/2024The companyPDFXBRL
202201/01/2022 – 31/12/202207/07/2023The companyPDF not statedXBRL
202101/01/2021 – 31/12/202106/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202021/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0246810121409/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 11.6mNo. 395 of 421
Better than 6% of the companies in the industry
Equity−DKK 194kNo. 321 of 431
Better than 26% of the companies in the industry
Number of employees7No. 158 of 431
Better than 63% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,657of 69,742
Better than 0%
No. 63,548of 69,964
Better than 9%
Same industry and fewer than 20 employees329 companies in the comparison
No. 310of 323
Better than 4%
No. 231of 329
Better than 30%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 24,749of 24,791
Better than 0%
No. 23,651of 24,909
Better than 5%
All companies of type A/S18,025 companies in the comparison
No. 17,704of 17,786
Better than 0%
No. 17,204of 18,024
Better than 5%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. 2cureX A/S−DKK 11.6m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. 2cureX A/S−DKK 17.5m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. 2cureX A/S−DKK 194k
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. 2cureX A/S7
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Precision ApS90%
2cureX A/S

Management

5 active registrations

Executive management

Executive management at 2cureX A/S
NameRoleAppointed
Ole ThastrupDirector10/02/2021

Board of directors

Board of directors at 2cureX A/S
NameRoleAppointed
Ole ThastrupBoard member14/08/2017
Tonni Bülow-NielsenChair of the board14/11/2023
Grith HagelBoard member29/02/2024
Patrick Markus AisherBoard member11/06/2024
Founders
Ole Thastrup
Former management (21)
Former management at 2cureX A/S
NameRoleAppointedResigned
Ole ThastrupCEO20/03/200609/02/2021
Per HartlevBoard member29/09/200809/01/2014
Ole Bitsch-JensenBoard member01/07/201126/03/2012
Povl André Bang BendzBoard member09/01/201413/08/2017
Tove Marianne HesseBoard member09/01/201414/08/2017
Ole ThastrupChair of the board09/01/201413/08/2017
Timm JessenBoard member09/01/201428/05/2020
Ulrich SpenglerBoard member09/01/201402/04/2019
Bo ChristensenBoard member12/01/201628/09/2017
Povl André Bang BendzChair of the board14/08/201713/11/2023
Jørgen DrejerBoard member14/08/201701/07/2022
Simon Hesse Vangsted HoffmannBoard member14/08/201702/04/2019
Juan Antonio Farré JovéBoard member28/09/201702/04/2019
Camilla Huse BondessonBoard member02/04/201931/12/2023
Nils Aage BrünnerBoard member02/07/202010/02/2023
Michael Jürgen LutzBoard member02/07/202010/02/2023
Fernando AndreuCEO10/02/202129/12/2023
Michael SchaeferBoard member24/05/202231/12/2023
Michael SchaeferBoard member01/07/202214/11/2022
Michel KlimkeitBoard member10/02/202331/12/2023
Povl André Bang BendzBoard member14/11/202331/12/2023

Signing rule: Selskabet tegnes af tre bestyrelsesmedlemmer i forening eller af selskabets administrerende direktør og bestyrelsesformanden i forening.

Address and production units

1 active production units

Fruebjergvej 3
2100 København Ø

København Municipality · Postcode 2100

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
2cureX A/SFruebjergvej 3, 2100 København Ø71012129668

Purpose

Selskabets formål er at drive virksomhed, rådgivning og assistance indenfor den farmaceutiske og bioteknologiske industri og beslægtede brancher samt anden dermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

88 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20253 changescapital 1 · accounts 1 · industry 1
  • Share capital changed from 500,000 DKK to 505,050 DKK
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20245 changesaccounts 1 · ownership 2 · management 2
  • Annual report for 2023 published
  • Precision ApS registered as owner (90%)
  • 2cureX AB is no longer registered as owner
  • Patrick Markus Aisher appointed board member
  • Grith Hagel appointed board member
202312 changesmanagement 11 · accounts 1
  • Povl André Bang Bendz stepped down as board member
  • Michel Klimkeit stepped down as board member
  • Michael Schaefer stepped down as board member
  • Camilla Huse Bondesson stepped down as board member
  • Fernando Andreu stepped down as ceo
  • Tonni Bülow-Nielsen appointed chair of the board
  • Povl André Bang Bendz appointed board member
  • Povl André Bang Bendz stepped down as chair of the board
  • Annual report for 2022 published
  • Michel Klimkeit appointed board member
  • Michael Jürgen Lutz stepped down as board member
  • Nils Aage Brünner stepped down as board member
20225 changesmanagement 4 · accounts 1
  • Michael Schaefer stepped down as board member
  • Annual report for 2021 published
  • Michael Schaefer appointed board member
  • Jørgen Drejer stepped down as board member
  • Michael Schaefer appointed board member
20214 changesaccounts 1 · management 3
  • Annual report for 2020 published
  • Ole Thastrup appointed director
  • Fernando Andreu appointed ceo
  • Ole Thastrup stepped down as ceo
20203 changesmanagement 3
  • Michael Jürgen Lutz appointed board member
  • Nils Aage Brünner appointed board member
  • Timm Jessen stepped down as board member
20194 changesmanagement 4
  • Camilla Huse Bondesson appointed board member
  • Juan Antonio Farré Jové stepped down as board member
  • Simon Hesse Vangsted Hoffmann stepped down as board member
  • Ulrich Spengler stepped down as board member
20181 changeaddress 1
  • Moved to Fruebjergvej 3, 2100 København Ø
201719 changesownership 8 · management 9 · name 1 · capital 1
  • 2cureX AB registered as owner (100%)
  • LISCO Beteiligungs- und Beratungsgesellschaft mbH is no longer registered as owner
  • Hviid Invest A/S is no longer registered as owner
  • DELTA READER A/S is no longer registered as owner
  • Tove Marianne Hesse is no longer registered as owner
  • Timm Jessen is no longer registered as owner
  • Grith Hagel is no longer registered as owner
  • OT311 ApS is no longer registered as owner
  • Juan Antonio Farré Jové appointed board member
  • Bo Christensen stepped down as board member
  • Name changed from 2CUREX ApS to 2cureX A/S
  • Share capital changed from 215,162 DKK to 500,000 DKK
  • Ole Thastrup appointed board member
  • Simon Hesse Vangsted Hoffmann appointed board member
  • Jørgen Drejer appointed board member
  • Povl André Bang Bendz appointed chair of the board
  • Tove Marianne Hesse stepped down as board member
  • Ole Thastrup stepped down as chair of the board
  • Povl André Bang Bendz stepped down as board member
20161 changemanagement 1
  • Bo Christensen appointed board member
20151 changecapital 1
  • Share capital changed from 7,647,202 DKK to 215,162 DKK
20147 changescapital 1 · management 6
  • Share capital changed from 185,902 DKK to 7,647,202 DKK
  • Timm Jessen appointed board member
  • Ulrich Spengler appointed board member
  • Ole Thastrup appointed chair of the board
  • Tove Marianne Hesse appointed board member
  • Povl André Bang Bendz appointed board member
  • Per Hartlev stepped down as board member
20131 changeownership 1
  • LISCO Beteiligungs- und Beratungsgesellschaft mbH registered as owner (10%)
20121 changemanagement 1
  • Ole Bitsch-Jensen stepped down as board member
20114 changescapital 2 · management 1 · ownership 1
  • Share capital changed from 177,206 DKK to 185,902 DKK
  • Ole Bitsch-Jensen appointed board member
  • Hviid Invest A/S registered as owner (5%)
  • Share capital changed from 176,306 DKK to 177,206 DKK
20105 changescapital 1 · ownership 4
  • Share capital changed from 151,551 DKK to 176,306 DKK
  • DELTA READER A/S registered as owner (10%)
  • Tove Marianne Hesse registered as owner (5%)
  • DELTA DANSK ELEKTRONIK, LYS & AKUSTIK registered as owner (10%)
  • DELTA DANSK ELEKTRONIK, LYS & AKUSTIK is no longer registered as owner
20083 changesmanagement 1 · capital 1 · industry 1
  • Per Hartlev appointed board member
  • Share capital changed from 146,551 DKK to 151,551 DKK
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20071 changeaddress 1
  • Moved to Birkevej 37, 3460 Birkerød
20067 changescapital 1 · ownership 3 · industry 1 · founded 1 · management 1
  • Share capital changed from 125,000 DKK to 146,551 DKK
  • Timm Jessen registered as owner (5%)
  • Industry changed to Forskning og udvikling inden for naturvidenskab og teknik (731000)
  • Registered as 2CUREX ApS
  • Ole Thastrup appointed ceo
  • Grith Hagel registered as owner (5%)
  • OT311 ApS registered as owner (33.33%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction